A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance
10.1371/journal.pone.0101904
Saved in:
Main Authors: | King T.H., Kemmler C.B., Guo Z., Mann D., Lu Y., Coeshott C., Gehring A.J., Bertoletti A., Ho Z.Z., Delaney W., Gaggar A., Subramanian G.M., McHutchison J.G., Shrivastava S., Lee Y.-J.L., Kottilil S., Bellgrau D., Rodell T., Apelian D. |
---|---|
其他作者: | DUKE-NUS MEDICAL SCHOOL |
格式: | Article |
出版: |
Public Library of Science
2018
|
在線閱讀: | http://scholarbank.nus.edu.sg/handle/10635/142461 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | National University of Singapore |
相似書籍
-
HBV-specific adaptive immunity
由: Bertoletti, A., et al.
出版: (2016) -
Therapeutic vaccination and novel strategies to treat chronic HBV infection
由: Bertoletti, A., et al.
出版: (2016) -
Trained immunity in newborn infants of HBV-infected mothers
由: Hong M., et al.
出版: (2016) -
B CELL IMMUNITY IN HBV INFECTION
由: LOGHMAN SALIMZADEH
出版: (2018) -
Tolerance and immunity to pathogens in early life: insights from HBV infection
由: Hong, M, et al.
出版: (2020)